A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors
Status:
Recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and tolerability of DS-1055a in
participants with relapsed or refractory locally advanced or metastatic solid tumors for
which no standard treatment is available.